Instrumento Inactivo

Acciones Alexza Pharmaceuticals, Inc. Nasdaq

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	28/03/16
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	15/03/16
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	09/03/16
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	27/02/16
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	24/02/16

Directores	Puesto	Edad	Desde
Stacy Palermini DFI	Director of Finance/CFO	-	01/01/03
Tatjana Naranda PSD	President	-	01/01/05
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	01/05/19

Administradores	Puesto	Edad	Desde
Jorge Ramentol Massana BRD	Director/Board Member	-	21/06/16
Joan Fanés Trillo BRD	Director/Board Member	-	21/06/16
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	21/06/16

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+16,61 %	122 mil M
REGENERON PHARMACEUTICALS, INC.	+17,75 %	112 mil M
ARGENX SE	+17,23 %	25,91 mil M
BIONTECH SE	-24,11 %	19,33 mil M
GENMAB A/S	-18,56 %	16,17 mil M
BEIGENE, LTD.	-18,47 %	15,6 mil M
WUXI APPTEC CO., LTD.	-47,75 %	14,65 mil M
SAREPTA THERAPEUTICS, INC.	+57,35 %	14,34 mil M
NEUROCRINE BIOSCIENCES, INC.	+5,62 %	14 mil M